Search results
Results from the WOW.Com Content Network
Head and neck cancer is a general term encompassing multiple cancers that can develop in the head and neck region. These include cancers of the mouth, tongue, gums and lips (oral cancer), voice box (), throat (nasopharyngeal, oropharyngeal, [1] hypopharyngeal), salivary glands, nose and sinuses.
Laryngeal cancer or throat cancer is a kind of cancer that can develop in any part of the larynx (voice box). It is typically a squamous-cell carcinoma , reflecting its origin from the epithelium of the larynx.
In 2015, squamous cell cancer of the head and neck region was the fifth most common cancer other than skin cancer, globally, with an annual incidence of 600,000 cases and about 60,000 cases annually in the United States and Europe. [218] The global incidence of pharyngeal cancer in 2013 was estimated at 136,000 cases.
The American Cancer Society estimates that in 2024, about 58,450 people in the U.S. will develop a type of oropharyngeal or oral cavity cancer, including tonsil cancer.
The American Cancer Society estimates more than 12,600 people will be diagnosed with some form of laryngeal cancer this year. While today many undergo voice-preserving treatment, thousands of people have had their larynx completely removed, breathing through what’s called a tracheostomy tube in their neck and struggling to communicate.
For premium support please call: 800-290-4726 more ways to reach us
An electrolarynx, sometimes referred to as a "throat back", is a medical device used to produce clearer speech by those people who have lost their voice box, usually due to cancer of the larynx.
Oropharyngeal cancer, [1] [2] [3] also known as oropharyngeal squamous cell carcinoma and tonsil cancer, [1] is a disease in which abnormal cells with the potential to both grow locally and spread to other parts of the body are found in the oral cavity, in the tissue of the part of the throat that includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx.